Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis
Anti-kelchlike protein 11 (KLHL11) encephalitis was first reported in 2019. This disease is very rare. The prevalence is higher in men than in women. Few female cases have been described. The most common clinical manifestations of this disease are syndromes affecting the brainstem and cerebellum. Th...
Saved in:
| Main Authors: | Min Deng, Fei Zeng, Zhaohong Kong, Tao Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1456840/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Efficacy of ofatumumab in refractory anti-NMDAR encephalitis: case series and literature review
by: Min Deng, et al.
Published: (2025-03-01) -
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
by: Wenlin Wu, et al.
Published: (2024-12-01) -
Case Report: Severe psoriasis skin lesions following ofatumumab treatment for multiple sclerosis
by: Wioletta Katarzyna Żukowicz-Wyrwa, et al.
Published: (2025-08-01) -
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01) -
Successful sequential treatment with ofatumumab followed by efgartigimod for refractory autoimmune encephalitis with dual anti-NMDAR and anti-GFAP antibody positivity: first case report
by: Xin Tu, et al.
Published: (2025-08-01)